ProteomicsMarket, by Product Type (Reagents and Kits (Microarray, Spectroscopy, X-rayCrystallography, Chromatography, Electrophoresis, Immunoassay, and Protein FractionationReagents), Instruments (Protein Microarray, Spectrometry (Mass Spectrometry andNMR Spectroscopy), Chromatography (HPLC Systems, Ion Chromatography, AffinityChromatography, and Supercritical Fluid Chromatography), Electrophoresis (GelElectrophoresis and Capillary Electrophoresis), Surface Plasmon Resonance,X-ray Crystallography, and Protein Fractionation Systems), by Application (DrugDiscovery, Clinical Diagnosis, Molecular Medicine, and Others), and by Region(North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026
Proteomics is a study of largescale proteomes. Proteomes are entire complements of protein expressed by atissue, cell or organism. Proteomics aims to interpret the roles of largenumber of proteins made from combining 22 genetically-encoded amino acids. Ithelps to understand the structure, function, and interactions of the entireprotein content in a specific organism. It is used to investigate proteinexpression, rates of protein production, degradation, modification of protein,protein movements in subcellular compartments, and protein-protein interaction.
Global Proteomics Market: Drivers
Key players in the market arefocused on introducing new and improved proteomics techniques, which isexpected to boost the proteomics market growth. For instance, in September2017, Bruker Corporation launched timsTOF Pro system for parallel accumulationand serial fragmentation (PASEF) mass spectrometry— using proprietary trappedion mobility spectrometry (TIMS) technology—to offer efficient data acquisitionspeed for shotgun proteomics.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2493
Moreover, in October 2018, BrukerCorporation introduced a next-generation workflow for the timsTOF Pro massspectrometer at Human Proteome Organization (HUPO). The platform for timsTOFPro workflow includes large-scale, reproducible, and accurate collision crosssection (ccs) values for tryptic peptides, fastpro, and ccs-based lipidomicsworkflow.
Moreover, in 2017, Diagenode, aprovider of complete solutions for epigenetics research and sample preparation,in collaboration with PreOmics GmbH, developer and provider of innovative toolsfor MS-based proteomics, launched new streamlined sample preparation solutionfor proteomic analyses. The new solution was developed by combining PreOmicsin-StageTip Kit (iST Kit) and the Diagenode Bioruptor sonication system toclean peptides for mass spectrometry (MS) analysis.
Global Proteomics Market:Regional Analysis
On the basis of region, theglobal proteomics market is segmented into North America, Latin America,Europe, Asia Pacific, Middle East, and Africa.
North America is expected toaccount for the largest market share in the proteomics market over the forecastperiod. The market growth is attributed to increasing collaboration andpartnership activities by key players in this region. For instance, in November2018, Thermo Fisher Scientific Inc. and Symphogen entered into a two-yearcollaborative partnership to deliver validated platform workflows forsimplified characterization and quality monitoring of complex therapeuticproteins. Under this agreement, Symphogen would have access to Thermo Fisher’sQ Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry(LC-MS/MS) system with BioPharma Option for creating, testing, and validatingthe platform workflows for intact and native mass analysis of therapeuticmonoclonal antibody (mAb) mixtures.
Browse Research Report:https://www.coherentmarketinsights.com/ongoing-insight/proteomics-market-2493
Moreover, Symphogen will focus onthe development of automated multi-attribute method (MAM) workflows formonitoring critical quality attributes of proteins using high-resolutionaccurate-mass mass spectrometry in a quality control environment.
Increasing government initiativesto promote research and development in proteomics, genomics, and bioinformaticsis expected to propel Asia Pacific proteomics market growth during the forecastperiod. For instance, the 13th International Conference on Proteomics,Genomics, and Bioinformatics will be held on May 10-11, 2019 in Tokyo, Japan. Thetheme of the conference will be ‘Leading Edge Innovations in Life Sciences’ andthe objective will be to explore the recent advancements and new methodologiesthat can be applied to the research to make proteomics and bioinformatics moreadvance. Target audience for the upcoming conference can be healthprofessionals, researchers and scientists, management/business leaders and/oragents, government/non-government community groups or individuals, professors,psychiatrist, and therapists.
Key players operating in theglobal proteomics market include, Thermo Fisher Scientific Corporation, AgilentTechnologies, Luminex Corporation, Danaher Corporation, Inc., Bio-RadLaboratories, Inc., GE Healthcare, Waters Corporation, Caprion Proteomics Inc.,PerkinElmer, Inc., Biognosys Inc., Bruker, Cell Signaling Technology, Inc.,Newomics, Inc., Proteome Sciences, Applied Biomics, Inc., Courtagen LifeSciences, Inc., Xcelris Genomics., Center for Genomic Sciences, and SeraPrognostics, Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2493
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offering action-readysyndicated research reports, custom market analysis, consulting services, andcompetitive analysis through various recommendations related to emerging markettrends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
